NIPG NIP Group | $6.90
-2.5% | 12/19/2024 | Initiated by | Maxim Group | Analyst J. Aarde | Buy | $12.00 | N/A | View details for Maxim Group rating of NIP Group (NASDAQ:NIPG) on 12/19/2024 |
BHST BioHarvest Sciences | $6.29
+1.5% | 12/18/2024 | Initiated by | Maxim Group | Analyst A. Vendetti | Buy | $12.00 | N/A | View details for Maxim Group rating of BioHarvest Sciences (NASDAQ:BHST) on 12/18/2024 |
UMAC Unusual Machines | $12.61
+19.5% | 12/18/2024 | Initiated by | Maxim Group | Analyst M. Galinko | Buy | $18.00 | N/A | View details for Maxim Group rating of Unusual Machines (NYSEAMERICAN:UMAC) on 12/18/2024 |
MDCX Medicus Pharma | $2.58
+5.3% | 12/17/2024 | Initiated by | Maxim Group | Analyst J. Mccarthy | Buy | $10.00 | N/A | View details for Maxim Group rating of Medicus Pharma (NASDAQ:MDCX) on 12/17/2024 |
NRSN NeuroSense Therapeutics | $1.36
+6.3% | 12/16/2024 | Reiterated by | Maxim Group | Analyst N. Rahman | Buy -> Hold | | N/A | View details for Maxim Group rating of NeuroSense Therapeutics (NASDAQ:NRSN) on 12/16/2024 |
CMCL Caledonia Mining | $9.32
+0.4% | 12/16/2024 | Initiated by | Maxim Group | - | Buy | $17.00 | N/A | View details for Maxim Group rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 12/16/2024 |
|
ATHE Alterity Therapeutics | $2.20
+4.8% | 12/12/2024 | Initiated by | Maxim Group | Analyst J. Mccarthy | Buy | $8.00 | N/A | View details for Maxim Group rating of Alterity Therapeutics (NASDAQ:ATHE) on 12/12/2024 |
EXROF Exro Technologies | $0.10
+2.4% | 12/10/2024 | Downgraded by | Maxim Group | Analyst T. Sullivan | Strong-Buy -> Hold | | N/A | View details for Maxim Group rating of Exro Technologies (OTCMKTS:EXROF) on 12/10/2024 |
NXL Nexalin Technology | $2.63
-14.1% | 12/5/2024 | Reiterated by | Maxim Group | Analyst A. Vendetti | Buy -> Hold | | N/A | View details for Maxim Group rating of Nexalin Technology (NASDAQ:NXL) on 12/5/2024 |
ARBE Arbe Robotics | $1.71
+4.9% | 11/29/2024 | Target Lowered by | Maxim Group | - | Buy | $4.00 -> $3.00 | N/A | View details for Maxim Group rating of Arbe Robotics (NASDAQ:ARBE) on 11/29/2024 |
OSTX OS Therapies | $3.97
+1.5% | 11/26/2024 | Initiated by | Maxim Group | Analyst J. Mccarthy | Buy | $8.00 | N/A | View details for Maxim Group rating of OS Therapies (NYSE:OSTX) on 11/26/2024 |
CING Cingulate | $4.10
| 11/20/2024 | Upgraded by | Maxim Group | Analyst N. Rahman | Hold -> Buy | | N/A | View details for Maxim Group rating of Cingulate (NASDAQ:CING) on 11/20/2024 |
SKYH Sky Harbour Group | $13.02
+2.5% | 11/20/2024 | Target Raised by | Maxim Group | - | Buy | $17.00 -> $25.00 | N/A | View details for Maxim Group rating of Sky Harbour Group (NYSEAMERICAN:SKYH) on 11/20/2024 |
RDZN Roadzen | $2.46
+20.0% | 11/15/2024 | Target Lowered by | Maxim Group | Analyst A. Klee | Buy -> Buy | $7.00 -> $4.00 | N/A | View details for Maxim Group rating of Roadzen (NASDAQ:RDZN) on 11/15/2024 |
FPAY FlexShopper | $1.43
-10.6% | 11/15/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $2.00 -> $4.00 | N/A | View details for Maxim Group rating of FlexShopper (NASDAQ:FPAY) on 11/15/2024 |
DLPN Dolphin Entertainment | $1.07
+1.9% | 11/15/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $8.00 -> $5.00 | N/A | View details for Maxim Group rating of Dolphin Entertainment (NASDAQ:DLPN) on 11/15/2024 |
BLTE Belite Bio | $64.12
+1.1% | 11/15/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $60.00 -> $110.00 | N/A | View details for Maxim Group rating of Belite Bio (NASDAQ:BLTE) on 11/15/2024 |
SRTS Sensus Healthcare | $7.10
-1.5% | 11/15/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $12.00 -> $14.00 | N/A | View details for Maxim Group rating of Sensus Healthcare (NASDAQ:SRTS) on 11/15/2024 |
NEOV NeoVolta | $4.71
+0.4% | 11/13/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $4.75 -> $7.50 | N/A | View details for Maxim Group rating of NeoVolta (NASDAQ:NEOV) on 11/13/2024 |
NUTX Nutex Health | $29.38
-0.1% | 11/12/2024 | Target Raised by | Maxim Group | Analyst A. Vendetti | Buy -> Buy | $45.00 -> $50.00 | N/A | View details for Maxim Group rating of Nutex Health (NASDAQ:NUTX) on 11/12/2024 |
TLPH Talphera | $0.64
+2.9% | 11/8/2024 | Upgraded by | Maxim Group | Analyst N. Rahman | Strong-Buy | | N/A | View details for Maxim Group rating of Talphera (NASDAQ:TLPH) on 11/8/2024 |
INUV Inuvo | $0.42
+4.0% | 11/8/2024 | Upgraded by | Maxim Group | Analyst J. Aarde | Strong-Buy | | N/A | View details for Maxim Group rating of Inuvo (NYSE:INUV) on 11/8/2024 |
GILD Gilead Sciences | $92.57
+1.6% | 11/8/2024 | Downgraded by | Maxim Group | Analyst M. Okunewitch | Buy -> Hold | | N/A | View details for Maxim Group rating of Gilead Sciences (NASDAQ:GILD) on 11/8/2024 |
QNCX Quince Therapeutics | $1.78
+1.1% | 11/7/2024 | Initiated by | Maxim Group | Analyst J. Mccarthy | Buy | $6.00 | N/A | View details for Maxim Group rating of Quince Therapeutics (NASDAQ:QNCX) on 11/7/2024 |
HURA TuHURA Biosciences | $4.48
+12.0% | 11/5/2024 | Initiated by | Maxim Group | Analyst J. Mccarthy | Buy | $15.00 | High | View details for Maxim Group rating of TuHURA Biosciences (NASDAQ:HURA) on 11/5/2024 |
SEAT Vivid Seats | $3.52
+4.1% | 11/4/2024 | Target Lowered by | Maxim Group | - | Buy | $9.00 -> $8.00 | High | View details for Maxim Group rating of Vivid Seats (NASDAQ:SEAT) on 11/4/2024 |
CMPS COMPASS Pathways | $3.97
+1.3% | 11/1/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $22.00 -> $12.00 | Medium | View details for Maxim Group rating of COMPASS Pathways (NASDAQ:CMPS) on 11/1/2024 |
AMZN Amazon.com | $224.92
+0.7% | 11/1/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $251.00 -> $260.00 | Low | View details for Maxim Group rating of Amazon.com (NASDAQ:AMZN) on 11/1/2024 |
CFR Cullen/Frost Bankers | $132.87
+1.2% | 11/1/2024 | Target Raised by | Maxim Group | - | Buy | $138.00 -> $149.00 | Low | View details for Maxim Group rating of Cullen/Frost Bankers (NYSE:CFR) on 11/1/2024 |
AAPL Apple | $254.49
+1.9% | 11/1/2024 | Target Raised by | Maxim Group | - | Hold -> Hold | $203.00 -> $215.00 | Medium | View details for Maxim Group rating of Apple (NASDAQ:AAPL) on 11/1/2024 |
EEX Emerald | $4.79
+3.0% | 10/31/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $11.00 -> $8.00 | Medium | View details for Maxim Group rating of Emerald (NYSE:EEX) on 10/31/2024 |
MSTR MicroStrategy | $364.20
+11.6% | 10/31/2024 | Target Raised by | Maxim Group | Analyst M. Galinko | Buy -> Buy | $193.00 -> $270.00 | Medium | View details for Maxim Group rating of MicroStrategy (NASDAQ:MSTR) on 10/31/2024 |
BMTX BM Technologies | $4.80
+0.6% | 10/28/2024 | Reiterated by | Maxim Group | Analyst M. Diana | Buy -> Hold | | Low | View details for Maxim Group rating of BM Technologies (NYSE:BMTX) on 10/28/2024 |
AIRE reAlpha Tech | $1.22
-16.4% | 10/25/2024 | Initiated by | Maxim Group | Analyst A. Klee | Buy | $3.00 | Low | View details for Maxim Group rating of reAlpha Tech (NASDAQ:AIRE) on 10/25/2024 |
LC LendingClub | $16.46
+1.0% | 10/25/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $16.00 -> $19.00 | Low | View details for Maxim Group rating of LendingClub (NYSE:LC) on 10/25/2024 |
BYON Beyond | $5.09
-1.7% | 10/25/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $33.00 -> $26.00 | High | View details for Maxim Group rating of Beyond (NYSE:BYON) on 10/25/2024 |
ANVS Annovis Bio | $4.37
-0.7% | 10/25/2024 | Upgraded by | Maxim Group | Analyst J. Mccarthy | Hold -> Buy | $25.00 | High | View details for Maxim Group rating of Annovis Bio (NYSE:ANVS) on 10/25/2024 |
AIM AIM ImmunoTech | $0.19
-0.6% | 10/22/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $2.00 -> $1.00 | Low | View details for Maxim Group rating of AIM ImmunoTech (NYSE:AIM) on 10/22/2024 |
BMI Badger Meter | $217.72
-0.3% | 10/18/2024 | Target Raised by | Maxim Group | - | Buy | $216.00 -> $235.00 | Medium | View details for Maxim Group rating of Badger Meter (NYSE:BMI) on 10/18/2024 |
NIC Nicolet Bankshares | $106.01
+0.5% | 10/17/2024 | Target Raised by | Maxim Group | Analyst Michael Diana | Buy -> Buy | $120.00 -> $124.00 | Medium | View details for Maxim Group rating of Nicolet Bankshares (NYSE:NIC) on 10/17/2024 |
This is the worst sign for the U.S. stock market in 50 years (Ad) The Dow recently posted its worst losing streak since 1974.
And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression.
Introducing "The Dead Zone"  Click here to see Dan's new, urgent warning about the U.S. market for 2025. |
ZOOZ ZOOZ Power | $2.82
+2.5% | 10/11/2024 | Upgraded by | Maxim Group | Analyst T. Sullivan | Strong-Buy | | Medium | View details for Maxim Group rating of ZOOZ Power (NASDAQ:ZOOZ) on 10/11/2024 |
DEF Defiance Silver | C$0.18
| 10/11/2024 | Upgraded by | Maxim Group | Analyst M. Galinko | Strong-Buy | | N/A | View details for Maxim Group rating of Defiance Silver (CVE:DEF) on 10/11/2024 |
OCGN Ocugen | $0.77
+0.3% | 10/15/2024 | Initiated by | Maxim Group | Analyst M. Okunewitch | Buy | $4.00 | High | View details for Maxim Group rating of Ocugen (NASDAQ:OCGN) on 10/15/2024 |
NXL Nexalin Technology | $2.63
-14.1% | 10/9/2024 | Initiated by | Maxim Group | Analyst A. Vendetti | Buy | $3.00 | High | View details for Maxim Group rating of Nexalin Technology (NASDAQ:NXL) on 10/9/2024 |
NEOV NeoVolta | $4.71
+0.4% | 10/1/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $4.25 -> $4.75 | Medium | View details for Maxim Group rating of NeoVolta (NASDAQ:NEOV) on 10/1/2024 |
LAES SEALSQ | $2.75
+36.8% | 9/27/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $2.25 -> $1.75 | Low | View details for Maxim Group rating of SEALSQ (NASDAQ:LAES) on 9/27/2024 |
CAPR Capricor Therapeutics | $13.07
+1.3% | 9/25/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $12.00 -> $25.00 | High | View details for Maxim Group rating of Capricor Therapeutics (NASDAQ:CAPR) on 9/25/2024 |
MESO Mesoblast | $14.63
-12.7% | 9/24/2024 | Upgraded by | Maxim Group | Analyst M. Okunewitch | Hold -> Buy | $12.00 | High | View details for Maxim Group rating of Mesoblast (NASDAQ:MESO) on 9/24/2024 |
ZVRA Zevra Therapeutics | $8.49
-0.6% | 9/24/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $18.00 -> $25.00 | High | View details for Maxim Group rating of Zevra Therapeutics (NASDAQ:ZVRA) on 9/24/2024 |
FBLG FibroBiologics | $2.25
+10.8% | 9/24/2024 | Initiated by | Maxim Group | Analyst M. Okunewitch | Buy | $12.00 | High | View details for Maxim Group rating of FibroBiologics (NASDAQ:FBLG) on 9/24/2024 |
NUTX Nutex Health | $29.38
-0.1% | 9/18/2024 | Initiated by | Maxim Group | Analyst A. Vendetti | Buy | $45.00 | High | View details for Maxim Group rating of Nutex Health (NASDAQ:NUTX) on 9/18/2024 |
CAPR Capricor Therapeutics | $13.07
+1.3% | 9/17/2024 | Reiterated by | Maxim Group | - | Buy -> Buy | $12.00 -> $12.00 | High | View details for Maxim Group rating of Capricor Therapeutics (NASDAQ:CAPR) on 9/17/2024 |
AMPG AmpliTech Group | $1.98
-1.0% | 9/16/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for Maxim Group rating of AmpliTech Group (NASDAQ:AMPG) on 9/16/2024 |
FEAM 5E Advanced Materials | $0.47
+3.6% | 9/12/2024 | Target Lowered by | Maxim Group | Analyst T. Sullivan | Buy -> Buy | $4.00 -> $1.25 | High | View details for Maxim Group rating of 5E Advanced Materials (NASDAQ:FEAM) on 9/12/2024 |
AAPL Apple | $254.49
+1.9% | 9/10/2024 | Reiterated by | Maxim Group | - | Hold -> Hold | $203.00 -> $203.00 | Low | View details for Maxim Group rating of Apple (NASDAQ:AAPL) on 9/10/2024 |
CELH Celsius | $27.01
-3.3% | 9/5/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $65.00 -> $50.00 | Low | View details for Maxim Group rating of Celsius (NASDAQ:CELH) on 9/5/2024 |
LGVN Longeveron | $1.65
+3.1% | 8/27/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $15.00 -> $6.00 | Low | View details for Maxim Group rating of Longeveron (NASDAQ:LGVN) on 8/27/2024 |
CYTH Cyclo Therapeutics | $0.63
+1.6% | 8/27/2024 | Reiterated by | Maxim Group | Analyst J. Mccarthy | Buy -> Hold | | Low | View details for Maxim Group rating of Cyclo Therapeutics (NASDAQ:CYTH) on 8/27/2024 |
LNW Light & Wonder | $85.42
-1.3% | 8/26/2024 | Initiated by | Maxim Group | Analyst T. Forte | Buy | $144.00 | Low | View details for Maxim Group rating of Light & Wonder (NASDAQ:LNW) on 8/26/2024 |
JAKK JAKKS Pacific | $26.31
+2.9% | 8/26/2024 | Initiated by | Maxim Group | Analyst T. Forte | Buy | $46.00 | Low | View details for Maxim Group rating of JAKKS Pacific (NASDAQ:JAKK) on 8/26/2024 |
RVPH Reviva Pharmaceuticals | $1.34
-10.7% | 8/16/2024 | Reiterated by | Maxim Group | Analyst J. Mccarthy | Buy -> Hold | | Low | View details for Maxim Group rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 8/16/2024 |
DARE Daré Bioscience | $2.71
-9.1% | 8/14/2024 | Reiterated by | Maxim Group | Analyst J. Mccarthy | Buy -> Hold | | Low | View details for Maxim Group rating of Daré Bioscience (NASDAQ:DARE) on 8/14/2024 |
PALT Paltalk | $1.68
+5.2% | 8/14/2024 | Reiterated by | Maxim Group | Analyst A. Klee | Buy -> Hold | | Low | View details for Maxim Group rating of Paltalk (NASDAQ:PALT) on 8/14/2024 |
AMPS Altus Power | $3.55
+2.3% | 8/12/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $5.50 -> $4.50 | Low | View details for Maxim Group rating of Altus Power (NYSE:AMPS) on 8/12/2024 |
MITK Mitek Systems | $11.43
+3.0% | 8/12/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $23.00 -> $13.00 | Low | View details for Maxim Group rating of Mitek Systems (NASDAQ:MITK) on 8/12/2024 |
LAND Gladstone Land | $10.54
+0.3% | 8/12/2024 | Downgraded by | Maxim Group | Analyst M. Diana | Buy -> Hold | | Low | View details for Maxim Group rating of Gladstone Land (NASDAQ:LAND) on 8/12/2024 |
PFLT PennantPark Floating Rate Capital | $10.68
-0.3% | 8/12/2024 | Upgraded by | Maxim Group | Analyst M. Diana | Hold -> Buy | $12.00 | Low | View details for Maxim Group rating of PennantPark Floating Rate Capital (NASDAQ:PFLT) on 8/12/2024 |
CELH Celsius | $27.01
-3.3% | 8/7/2024 | Target Lowered by | Maxim Group | - | Buy | $90.00 -> $65.00 | Low | View details for Maxim Group rating of Celsius (NASDAQ:CELH) on 8/7/2024 |
ATNM Actinium Pharmaceuticals | $1.29
+15.2% | 8/6/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $30.00 -> $5.00 | Low | View details for Maxim Group rating of Actinium Pharmaceuticals (NYSE:ATNM) on 8/6/2024 |
RZLT Rezolute | $4.39
+3.8% | 8/6/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $8.00 -> $10.00 | Low | View details for Maxim Group rating of Rezolute (NASDAQ:RZLT) on 8/6/2024 |
MSTR MicroStrategy | $364.20
+11.6% | 8/2/2024 | Target Raised by | Maxim Group | Analyst M. Galinko | Buy -> Buy | $183.50 -> $193.00 | Low | View details for Maxim Group rating of MicroStrategy (NASDAQ:MSTR) on 8/2/2024 |
AAPL Apple | $254.49
+1.9% | 8/2/2024 | Target Raised by | Maxim Group | - | Hold -> Hold | $195.00 -> $203.00 | Low | View details for Maxim Group rating of Apple (NASDAQ:AAPL) on 8/2/2024 |
AMZN Amazon.com | $224.92
+0.7% | 8/2/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $238.00 -> $251.00 | Low | View details for Maxim Group rating of Amazon.com (NASDAQ:AMZN) on 8/2/2024 |
CFR Cullen/Frost Bankers | $132.87
+1.2% | 7/26/2024 | Target Raised by | Maxim Group | - | Buy | $132.00 -> $138.00 | Low | View details for Maxim Group rating of Cullen/Frost Bankers (NYSE:CFR) on 7/26/2024 |
ASRT Assertio | $0.89
+5.1% | 7/26/2024 | Initiated by | Maxim Group | Analyst N. Rahman | Buy | $3.00 | Low | View details for Maxim Group rating of Assertio (NASDAQ:ASRT) on 7/26/2024 |
BNAI Brand Engagement Network | $0.69
-3.6% | 7/25/2024 | Initiated by | Maxim Group | Analyst J. Aarde | Buy | $6.00 | Low | View details for Maxim Group rating of Brand Engagement Network (NASDAQ:BNAI) on 7/25/2024 |
AGNC AGNC Investment | $9.45
+1.9% | 7/24/2024 | Downgraded by | Maxim Group | Analyst M. Diana | Buy -> Hold | | Low | View details for Maxim Group rating of AGNC Investment (NASDAQ:AGNC) on 7/24/2024 |
BIAF bioAffinity Technologies | $0.99
-15.9% | 7/23/2024 | Initiated by | Maxim Group | Analyst A. Vendetti | Buy | $6.00 | Low | View details for Maxim Group rating of bioAffinity Technologies (NASDAQ:BIAF) on 7/23/2024 |
WABC Westamerica Bancorporation | $51.73
+0.6% | 7/22/2024 | Downgraded by | Maxim Group | Analyst M. Diana | Buy -> Hold | | Low | View details for Maxim Group rating of Westamerica Bancorporation (NASDAQ:WABC) on 7/22/2024 |
MDWD MediWound | $16.49
-4.1% | 7/16/2024 | Target Raised by | Maxim Group | - | Buy | $25.00 -> $30.00 | Low | View details for Maxim Group rating of MediWound (NASDAQ:MDWD) on 7/16/2024 |
INOD Innodata | $43.01
+8.2% | 7/15/2024 | Initiated by | Maxim Group | Analyst A. Klee | Buy | $30.00 | Low | View details for Maxim Group rating of Innodata (NASDAQ:INOD) on 7/15/2024 |
BCLI Brainstorm Cell Therapeutics | $2.28
+9.6% | 7/11/2024 | Upgraded by | Maxim Group | Analyst J. Mccarthy | Hold -> Buy | $30.00 | Low | View details for Maxim Group rating of Brainstorm Cell Therapeutics (NASDAQ:BCLI) on 7/11/2024 |
USEA United Maritime | $1.83
+1.1% | 6/27/2024 | Upgraded by | Maxim Group | Analyst T. Sullivan | Strong-Buy | | Low | View details for Maxim Group rating of United Maritime (NASDAQ:USEA) on 6/27/2024 |
MSTR MicroStrategy | $364.20
+11.6% | 6/27/2024 | Upgraded by | Maxim Group | Analyst M. Galinko | Strong-Buy | | Low | View details for Maxim Group rating of MicroStrategy (NASDAQ:MSTR) on 6/27/2024 |
USEA United Maritime | $1.83
+1.1% | 6/26/2024 | Initiated by | Maxim Group | - | Buy | $6.00 | Low | View details for Maxim Group rating of United Maritime (NASDAQ:USEA) on 6/26/2024 |
AAPL Apple | $254.49
+1.9% | 6/25/2024 | Target Raised by | Maxim Group | - | Hold | $178.00 -> $195.00 | Low | View details for Maxim Group rating of Apple (NASDAQ:AAPL) on 6/25/2024 |
MSTR MicroStrategy | $364.20
+11.6% | 6/25/2024 | Initiated by | Maxim Group | - | Buy | $183.50 | Low | View details for Maxim Group rating of MicroStrategy (NASDAQ:MSTR) on 6/25/2024 |
VIRI Virios Therapeutics | $2.32
-4.1% | 6/20/2024 | Initiated by | Maxim Group | Analyst J. Mccarthy | Buy | $1.00 | Low | View details for Maxim Group rating of Virios Therapeutics (NASDAQ:VIRI) on 6/20/2024 |
CELH Celsius | $27.01
-3.3% | 6/18/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $110.00 -> $90.00 | Low | View details for Maxim Group rating of Celsius (NASDAQ:CELH) on 6/18/2024 |
LOVE Lovesac | $23.93
+2.2% | 6/17/2024 | Target Raised by | Maxim Group | - | Buy | $36.00 -> $38.00 | Low | View details for Maxim Group rating of Lovesac (NASDAQ:LOVE) on 6/17/2024 |
This is the worst sign for the U.S. stock market in 50 years (Ad) The Dow recently posted its worst losing streak since 1974.
And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression.
Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025. |
RANI Rani Therapeutics | $1.40
+7.7% | 6/13/2024 | Upgraded by | Maxim Group | Analyst M. Okunewitch | Strong-Buy | | Low | View details for Maxim Group rating of Rani Therapeutics (NASDAQ:RANI) on 6/13/2024 |
RANI Rani Therapeutics | $1.40
+7.7% | 6/14/2024 | Initiated by | Maxim Group | - | Buy | $15.00 | Low | View details for Maxim Group rating of Rani Therapeutics (NASDAQ:RANI) on 6/14/2024 |
WINA Winmark | $398.65
+0.0% | 6/13/2024 | Initiated by | Maxim Group | Analyst T. Forte | Buy | $445.00 | Low | View details for Maxim Group rating of Winmark (NASDAQ:WINA) on 6/13/2024 |
LAKE Lakeland Industries | $22.88
+0.4% | 6/6/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $22.00 -> $26.00 | Low | View details for Maxim Group rating of Lakeland Industries (NASDAQ:LAKE) on 6/6/2024 |
VKTX Viking Therapeutics | $42.25
+1.8% | 6/4/2024 | Reiterated by | Maxim Group | - | Buy -> Buy | $120.00 -> $120.00 | Low | View details for Maxim Group rating of Viking Therapeutics (NASDAQ:VKTX) on 6/4/2024 |
ZIVO ZIVO Bioscience | $19.00
+0.9% | 6/4/2024 | Reiterated by | Maxim Group | Analyst A. Vendetti | Buy -> Hold | | N/A | View details for Maxim Group rating of ZIVO Bioscience (NASDAQ:ZIVO) on 6/4/2024 |
CMMB Chemomab Therapeutics | $1.68
+3.7% | 5/24/2024 | Upgraded by | Maxim Group | Analyst M. Okunewitch | Strong-Buy | | Low | View details for Maxim Group rating of Chemomab Therapeutics (NASDAQ:CMMB) on 5/24/2024 |
RDZN Roadzen | $2.46
+20.0% | 5/23/2024 | Initiated by | Maxim Group | Analyst A. Klee | Buy | $10.00 | Low | View details for Maxim Group rating of Roadzen (NASDAQ:RDZN) on 5/23/2024 |
FEAM 5E Advanced Materials | $0.47
+3.6% | 5/23/2024 | Initiated by | Maxim Group | Analyst T. Sullivan | Hold -> Buy | $4.00 | Low | View details for Maxim Group rating of 5E Advanced Materials (NASDAQ:FEAM) on 5/23/2024 |
GCT GigaCloud Technology | $17.93
+1.2% | 5/22/2024 | Initiated by | Maxim Group | Analyst T. Forte | Buy | $69.00 | Low | View details for Maxim Group rating of GigaCloud Technology (NASDAQ:GCT) on 5/22/2024 |
AMRK A-Mark Precious Metals | $25.79
-1.0% | 5/22/2024 | Initiated by | Maxim Group | Analyst T. Forte | Buy | $63.00 | Low | View details for Maxim Group rating of A-Mark Precious Metals (NASDAQ:AMRK) on 5/22/2024 |
SPI SPI Energy | $0.43
+8.2% | 5/21/2024 | Reiterated by | Maxim Group | Analyst T. Sullivan | Buy -> Hold | | Low | View details for Maxim Group rating of SPI Energy (NASDAQ:SPI) on 5/21/2024 |
TTEK Tetra Tech | $40.20
-0.2% | 5/16/2024 | Target Raised by | Maxim Group | - | Buy | $46.80 -> $53.60 | Low | View details for Maxim Group rating of Tetra Tech (NASDAQ:TTEK) on 5/16/2024 |
CMMB Chemomab Therapeutics | $1.68
+3.7% | 5/13/2024 | Initiated by | Maxim Group | - | Buy | $4.00 | Low | View details for Maxim Group rating of Chemomab Therapeutics (NASDAQ:CMMB) on 5/13/2024 |
FLUX Flux Power | $1.71
+7.5% | 5/10/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $9.00 -> $6.00 | Low | View details for Maxim Group rating of Flux Power (NASDAQ:FLUX) on 5/10/2024 |
PALT Paltalk | $1.68
+5.2% | 5/10/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $5.00 -> $4.50 | Low | View details for Maxim Group rating of Paltalk (NASDAQ:PALT) on 5/10/2024 |
RSSS Research Solutions | $3.93
-0.3% | 5/10/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $5.00 -> $6.00 | Low | View details for Maxim Group rating of Research Solutions (NASDAQ:RSSS) on 5/10/2024 |
SRTS Sensus Healthcare | $7.10
-1.5% | 5/10/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $7.00 -> $10.00 | Low | View details for Maxim Group rating of Sensus Healthcare (NASDAQ:SRTS) on 5/10/2024 |
HAIN The Hain Celestial Group | $6.42
-1.8% | 5/9/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $18.00 -> $15.00 | Low | View details for Maxim Group rating of The Hain Celestial Group (NASDAQ:HAIN) on 5/9/2024 |
LAND Gladstone Land | $10.54
+0.3% | 5/9/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $19.00 -> $16.00 | Low | View details for Maxim Group rating of Gladstone Land (NASDAQ:LAND) on 5/9/2024 |
CNTX Context Therapeutics | $1.02
-6.4% | 5/9/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $4.00 -> $10.00 | Low | View details for Maxim Group rating of Context Therapeutics (NASDAQ:CNTX) on 5/9/2024 |
PAYS Paysign | $2.99
+2.0% | 5/8/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $5.50 -> $6.00 | Low | View details for Maxim Group rating of Paysign (NASDAQ:PAYS) on 5/8/2024 |
SEAT Vivid Seats | $3.52
+4.1% | 5/8/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $7.00 -> $9.00 | Low | View details for Maxim Group rating of Vivid Seats (NASDAQ:SEAT) on 5/8/2024 |
NRBO NeuroBo Pharmaceuticals | $1.60
-9.1% | 5/8/2024 | Initiated by | Maxim Group | Analyst J. Mccarthy | Buy | $10.00 | Low | View details for Maxim Group rating of NeuroBo Pharmaceuticals (NASDAQ:NRBO) on 5/8/2024 |
BYON Beyond | $5.09
-1.7% | 5/8/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $50.00 -> $36.00 | Low | View details for Maxim Group rating of Beyond (NYSE:BYON) on 5/8/2024 |
TLPH Talphera | $0.64
+2.9% | 5/6/2024 | Initiated by | Maxim Group | - | Buy | $3.00 | Low | View details for Maxim Group rating of Talphera (NASDAQ:TLPH) on 5/6/2024 |
GILD Gilead Sciences | $92.57
+1.6% | 5/1/2024 | Target Lowered by | Maxim Group | - | Buy | $90.00 -> $85.00 | Low | View details for Maxim Group rating of Gilead Sciences (NASDAQ:GILD) on 5/1/2024 |
AMZN Amazon.com | $224.92
+0.7% | 5/1/2024 | Target Lowered by | Maxim Group | - | Buy | $318.00 -> $238.00 | Low | View details for Maxim Group rating of Amazon.com (NASDAQ:AMZN) on 5/1/2024 |
TTEK Tetra Tech | $40.20
-0.2% | 4/30/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $44.00 -> $46.00 | Low | View details for Maxim Group rating of Tetra Tech (NASDAQ:TTEK) on 4/30/2024 |
ENVA Enova International | $96.47
+1.6% | 4/25/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $70.00 -> $78.00 | Low | View details for Maxim Group rating of Enova International (NYSE:ENVA) on 4/25/2024 |
LAKE Lakeland Industries | $22.88
+0.4% | 4/24/2024 | Initiated by | Maxim Group | - | Buy | $22.00 | Low | View details for Maxim Group rating of Lakeland Industries (NASDAQ:LAKE) on 4/24/2024 |
BMI Badger Meter | $217.72
-0.3% | 4/19/2024 | Target Raised by | Maxim Group | - | Buy | $190.00 -> $207.00 | Low | View details for Maxim Group rating of Badger Meter (NYSE:BMI) on 4/19/2024 |
SEAT Vivid Seats | $3.52
+4.1% | 4/17/2024 | Initiated by | Maxim Group | - | Buy | $7.00 | Low | View details for Maxim Group rating of Vivid Seats (NASDAQ:SEAT) on 4/17/2024 |
LOVE Lovesac | $23.93
+2.2% | 4/17/2024 | Initiated by | Maxim Group | - | Buy | $36.00 | Low | View details for Maxim Group rating of Lovesac (NASDAQ:LOVE) on 4/17/2024 |
BYON Beyond | $5.09
-1.7% | 4/17/2024 | Initiated by | Maxim Group | - | Buy | $50.00 | Low | View details for Maxim Group rating of Beyond (NYSE:BYON) on 4/17/2024 |
AMZN Amazon.com | $224.92
+0.7% | 4/17/2024 | Initiated by | Maxim Group | - | Buy | $218.00 | Low | View details for Maxim Group rating of Amazon.com (NASDAQ:AMZN) on 4/17/2024 |
AAPL Apple | $254.49
+1.9% | 4/17/2024 | Initiated by | Maxim Group | - | Hold | $178.00 | Low | View details for Maxim Group rating of Apple (NASDAQ:AAPL) on 4/17/2024 |
AMPS Altus Power | $3.55
+2.3% | 4/10/2024 | Initiated by | Maxim Group | - | Buy | $7.00 | Low | View details for Maxim Group rating of Altus Power (NYSE:AMPS) on 4/10/2024 |
RZLT Rezolute | $4.39
+3.8% | 4/9/2024 | Initiated by | Maxim Group | - | Buy | $8.00 | Low | View details for Maxim Group rating of Rezolute (NASDAQ:RZLT) on 4/9/2024 |
ATAI Atai Life Sciences | $1.19
| 4/3/2024 | Upgraded by | Maxim Group | - | Hold -> Buy | $6.00 | N/A | View details for Maxim Group rating of Atai Life Sciences (NASDAQ:ATAI) on 4/3/2024 |
ZVRA Zevra Therapeutics | $8.49
-0.6% | 4/2/2024 | Target Raised by | Maxim Group | - | Buy | $12.00 -> $18.00 | Low | View details for Maxim Group rating of Zevra Therapeutics (NASDAQ:ZVRA) on 4/2/2024 |
CELH Celsius | $27.01
-3.3% | 4/1/2024 | Target Raised by | Maxim Group | - | Buy | $100.00 -> $110.00 | Low | View details for Maxim Group rating of Celsius (NASDAQ:CELH) on 4/1/2024 |
MRAI Marpai | $0.98
-7.3% | 3/28/2024 | Upgraded by | Maxim Group | - | Hold -> Buy | $6.00 | N/A | View details for Maxim Group rating of Marpai (NASDAQ:MRAI) on 3/28/2024 |
LUCY Innovative Eyewear | $5.70
-3.4% | 3/26/2024 | Target Lowered by | Maxim Group | - | Buy -> Buy | $35.00 -> $20.00 | Low | View details for Maxim Group rating of Innovative Eyewear (NASDAQ:LUCY) on 3/26/2024 |
CCLD CareCloud | $3.40
-2.6% | 3/22/2024 | Upgraded by | Maxim Group | - | Hold -> Buy | $3.00 | Low | View details for Maxim Group rating of CareCloud (NASDAQ:CCLD) on 3/22/2024 |
ATNM Actinium Pharmaceuticals | $1.29
+15.2% | 3/19/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for Maxim Group rating of Actinium Pharmaceuticals (NYSE:ATNM) on 3/19/2024 |
HEAR Turtle Beach | $15.96
-1.2% | 3/15/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $18.00 -> $24.00 | N/A | View details for Maxim Group rating of Turtle Beach (NASDAQ:HEAR) on 3/15/2024 |
VKTX Viking Therapeutics | $42.25
+1.8% | 3/15/2024 | Reiterated by | Maxim Group | - | Buy -> Buy | $120.00 | Low | View details for Maxim Group rating of Viking Therapeutics (NASDAQ:VKTX) on 3/15/2024 |
SURG SurgePays | $1.77
+2.3% | 3/13/2024 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of SurgePays (NASDAQ:SURG) on 3/13/2024 |
LEXX Lexaria Bioscience | $2.23
+0.9% | 3/5/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $3.00 -> $12.00 | Low | View details for Maxim Group rating of Lexaria Bioscience (NASDAQ:LEXX) on 3/5/2024 |
This is the worst sign for the U.S. stock market in 50 years (Ad) The Dow recently posted its worst losing streak since 1974.
And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression.
Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025. |
CELH Celsius | $27.01
-3.3% | 3/1/2024 | Target Raised by | Maxim Group | - | Buy | $65.00 -> $100.00 | Low | View details for Maxim Group rating of Celsius (NASDAQ:CELH) on 3/1/2024 |
VKTX Viking Therapeutics | $42.25
+1.8% | 2/8/2024 | Target Raised by | Maxim Group | - | Buy -> Buy | $35.00 -> $50.00 | Low | View details for Maxim Group rating of Viking Therapeutics (NASDAQ:VKTX) on 2/8/2024 |
HAIN The Hain Celestial Group | $6.42
-1.8% | 2/8/2024 | Target Lowered by | Maxim Group | - | Buy | $25.00 -> $18.00 | Low | View details for Maxim Group rating of The Hain Celestial Group (NASDAQ:HAIN) on 2/8/2024 |
CELH Celsius | $27.01
-3.3% | 2/2/2024 | Upgraded by | Maxim Group | - | Hold -> Buy | $65.00 | Low | View details for Maxim Group rating of Celsius (NASDAQ:CELH) on 2/2/2024 |
VRTX Vertex Pharmaceuticals | $397.27
+0.2% | 1/31/2024 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/31/2024 |
MLEC Moolec Science | $0.85
-1.7% | 1/30/2024 | Initiated by | Maxim Group | - | Buy | $6.00 | Low | View details for Maxim Group rating of Moolec Science (NASDAQ:MLEC) on 1/30/2024 |
SCWO 374Water | $0.75
+1.7% | 1/3/2024 | Initiated by | Maxim Group | - | Buy | $3.00 | Low | View details for Maxim Group rating of 374Water (NASDAQ:SCWO) on 1/3/2024 |
MAMA Mama's Creations | $7.45
-0.7% | 12/20/2023 | Initiated by | Maxim Group | - | Buy | $10.00 | Low | View details for Maxim Group rating of Mama’s Creations (NASDAQ:MAMA) on 12/20/2023 |
CING Cingulate | $4.10
| 12/18/2023 | Reiterated by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Cingulate (NASDAQ:CING) on 12/18/2023 |
BLTE Belite Bio | $64.12
+1.1% | 12/14/2023 | Initiated by | Maxim Group | - | Buy | $60.00 | Low | View details for Maxim Group rating of Belite Bio (NASDAQ:BLTE) on 12/14/2023 |
CRGE Charge Enterprises | $1.10
+5.1% | 11/24/2023 | Reiterated by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Charge Enterprises (NASDAQ:CRGE) on 11/24/2023 |
WISA WiSA Technologies | $1.70
-1.2% | 11/20/2023 | Reiterated by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of WiSA Technologies (NASDAQ:WISA) on 11/20/2023 |
RNXT RenovoRx | $1.25
+8.7% | 11/15/2023 | Reiterated by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of RenovoRx (NASDAQ:RNXT) on 11/15/2023 |
MRAI Marpai | $0.98
-7.3% | 11/14/2023 | Reiterated by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Marpai (NASDAQ:MRAI) on 11/14/2023 |
BNGO Bionano Genomics | $0.20
-2.7% | 11/13/2023 | Reiterated by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Bionano Genomics (NASDAQ:BNGO) on 11/13/2023 |
CHRS Coherus BioSciences | $1.52
+2.7% | 11/8/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Coherus BioSciences (NASDAQ:CHRS) on 11/8/2023 |
GP GreenPower Motor | $0.75
-2.3% | 10/23/2023 | Target Lowered by | Maxim Group | - | Buy -> Buy | $7.00 -> $6.00 | Low | View details for Maxim Group rating of GreenPower Motor (NASDAQ:GP) on 10/23/2023 |
SKYH Sky Harbour Group | $13.02
+2.5% | 10/17/2023 | Initiated by | Maxim Group | - | Buy | $11.00 | N/A | View details for Maxim Group rating of Sky Harbour Group (NYSEAMERICAN:SKYH) on 10/17/2023 |
RMTI Rockwell Medical | $2.08
+1.5% | 10/5/2023 | Initiated by | Maxim Group | - | Buy | $5.00 | Low | View details for Maxim Group rating of Rockwell Medical (NASDAQ:RMTI) on 10/5/2023 |
ACRV Acrivon Therapeutics | $6.71
+0.3% | 10/5/2023 | Initiated by | Maxim Group | - | Buy | $24.00 | Low | View details for Maxim Group rating of Acrivon Therapeutics (NASDAQ:ACRV) on 10/5/2023 |
WKEY WISeKey International | $6.99
+16.5% | 10/4/2023 | Target Lowered by | Maxim Group | - | Buy -> Buy | $15.00 -> $6.00 | Low | View details for Maxim Group rating of WISeKey International (NASDAQ:WKEY) on 10/4/2023 |
BCLI Brainstorm Cell Therapeutics | $2.28
+9.6% | 9/28/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Brainstorm Cell Therapeutics (NASDAQ:BCLI) on 9/28/2023 |
CYTH Cyclo Therapeutics | $0.63
+1.6% | 9/27/2023 | Upgraded by | Maxim Group | - | Hold -> Buy | $4.00 | Low | View details for Maxim Group rating of Cyclo Therapeutics (NASDAQ:CYTH) on 9/27/2023 |
ANEB Anebulo Pharmaceuticals | $0.99
-10.8% | 9/21/2023 | Initiated by | Maxim Group | - | Buy | $6.00 | Low | View details for Maxim Group rating of Anebulo Pharmaceuticals (NASDAQ:ANEB) on 9/21/2023 |
HAIN The Hain Celestial Group | $6.42
-1.8% | 9/14/2023 | Reiterated by | Maxim Group | - | Buy -> Buy | $30.00 | Low | View details for Maxim Group rating of The Hain Celestial Group (NASDAQ:HAIN) on 9/14/2023 |
RSSS Research Solutions | $3.93
-0.3% | 9/14/2023 | Reiterated by | Maxim Group | - | Buy -> Buy | $5.00 | Low | View details for Maxim Group rating of Research Solutions (NASDAQ:RSSS) on 9/14/2023 |
CTGO Contango Ore | $10.30
+0.6% | 9/14/2023 | Initiated by | Maxim Group | - | Buy | $36.00 | N/A | View details for Maxim Group rating of Contango Ore (NYSEAMERICAN:CTGO) on 9/14/2023 |
CXAI CXApp | $1.59
+0.6% | 9/13/2023 | Initiated by | Maxim Group | - | Buy | | Low | View details for Maxim Group rating of CXApp (NASDAQ:CXAI) on 9/13/2023 |
GANX Gain Therapeutics | $1.56
-0.6% | 9/12/2023 | Initiated by | Maxim Group | - | Buy | $10.00 | Low | View details for Maxim Group rating of Gain Therapeutics (NASDAQ:GANX) on 9/12/2023 |
GNLX Genelux | $2.27
+3.7% | 9/12/2023 | Initiated by | Maxim Group | - | Buy | $40.00 | Low | View details for Maxim Group rating of Genelux (NASDAQ:GNLX) on 9/12/2023 |
CNTX Context Therapeutics | $1.02
-6.4% | 9/11/2023 | Initiated by | Maxim Group | - | Buy | $4.00 | Low | View details for Maxim Group rating of Context Therapeutics (NASDAQ:CNTX) on 9/11/2023 |
LUCY Innovative Eyewear | $5.70
-3.4% | 9/11/2023 | Initiated by | Maxim Group | - | Buy | $35.00 | Low | View details for Maxim Group rating of Innovative Eyewear (NASDAQ:LUCY) on 9/11/2023 |
VTGN Vistagen Therapeutics | $2.50
+11.1% | 9/5/2023 | Reiterated by | Maxim Group | - | Buy -> Buy | $30.00 | Low | View details for Maxim Group rating of Vistagen Therapeutics (NASDAQ:VTGN) on 9/5/2023 |
BMTX BM Technologies | $4.80
+0.6% | 8/25/2023 | Target Lowered by | Maxim Group | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for Maxim Group rating of BM Technologies (NYSE:BMTX) on 8/25/2023 |
PSHG Performance Shipping | $1.76
+2.9% | 8/25/2023 | Initiated by | Maxim Group | - | Buy | | Low | View details for Maxim Group rating of Performance Shipping (NASDAQ:PSHG) on 8/25/2023 |
GASS StealthGas | $4.88
+0.2% | 8/21/2023 | Target Raised by | Maxim Group | - | Buy -> Buy | $7.00 -> $8.00 | Low | View details for Maxim Group rating of StealthGas (NASDAQ:GASS) on 8/21/2023 |
TTEK Tetra Tech | $40.20
-0.2% | 8/11/2023 | Target Raised by | Maxim Group | - | | $40.00 -> $43.00 | Low | View details for Maxim Group rating of Tetra Tech (NASDAQ:TTEK) on 8/11/2023 |
JYNT Joint | $10.27
-0.2% | 8/11/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Joint (NASDAQ:JYNT) on 8/11/2023 |
VTGN Vistagen Therapeutics | $2.50
+11.1% | 8/7/2023 | Upgraded by | Maxim Group | - | Hold -> Buy | $30.00 | Low | View details for Maxim Group rating of Vistagen Therapeutics (NASDAQ:VTGN) on 8/7/2023 |
BWXT BWX Technologies | $113.28
+0.3% | 8/7/2023 | Target Raised by | Maxim Group | - | Buy -> Buy | $75.00 -> $85.00 | Low | View details for Maxim Group rating of BWX Technologies (NYSE:BWXT) on 8/7/2023 |
MESO Mesoblast | $14.63
-12.7% | 8/7/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Mesoblast (NASDAQ:MESO) on 8/7/2023 |
CCLD CareCloud | $3.40
-2.6% | 8/4/2023 | Target Lowered by | Maxim Group | - | | $13.00 -> $6.00 | Low | View details for Maxim Group rating of CareCloud (NASDAQ:CCLD) on 8/4/2023 |
CUBI Customers Bancorp | $47.71
+1.6% | 7/31/2023 | Target Raised by | Maxim Group | - | Buy -> Buy | $45.00 -> $55.00 | Low | View details for Maxim Group rating of Customers Bancorp (NYSE:CUBI) on 7/31/2023 |
ARBB ARB IOT Group | $0.41
+4.1% | 7/28/2023 | Initiated by | Maxim Group | - | Buy | $8.00 | Low | View details for Maxim Group rating of ARB IOT Group (NASDAQ:ARBB) on 7/28/2023 |
BMI Badger Meter | $217.72
-0.3% | 7/21/2023 | Target Raised by | Maxim Group | - | Buy | $152.00 -> $180.00 | Low | View details for Maxim Group rating of Badger Meter (NYSE:BMI) on 7/21/2023 |
LEXX Lexaria Bioscience | $2.23
+0.9% | 7/21/2023 | Initiated by | Maxim Group | - | Buy | $2.00 | Low | View details for Maxim Group rating of Lexaria Bioscience (NASDAQ:LEXX) on 7/21/2023 |
NIC Nicolet Bankshares | $106.01
+0.5% | 7/20/2023 | Target Raised by | Maxim Group | - | | $70.00 -> $95.00 | Low | View details for Maxim Group rating of Nicolet Bankshares (NYSE:NIC) on 7/20/2023 |
CELH Celsius | $27.01
-3.3% | 7/19/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Celsius (NASDAQ:CELH) on 7/19/2023 |
KURA Kura Oncology | $9.01
+0.4% | 7/14/2023 | Upgraded by | Maxim Group | - | Hold -> Buy | | Low | View details for Maxim Group rating of Kura Oncology (NASDAQ:KURA) on 7/14/2023 |
UNCY Unicycive Therapeutics | $0.68
-4.2% | 7/3/2023 | Target Lowered by | Maxim Group | - | | $6.00 -> $4.00 | Low | View details for Maxim Group rating of Unicycive Therapeutics (NASDAQ:UNCY) on 7/3/2023 |
This is the worst sign for the U.S. stock market in 50 years (Ad) The Dow recently posted its worst losing streak since 1974.
And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression.
Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025. |
VOXR Vox Royalty | $2.35
+3.5% | 6/29/2023 | Initiated by | Maxim Group | - | Buy | | Low | View details for Maxim Group rating of Vox Royalty (NASDAQ:VOXR) on 6/29/2023 |
MYO Myomo | $6.12
+0.5% | 5/25/2023 | Initiated by | Maxim Group | - | Buy | | N/A | View details for Maxim Group rating of Myomo (NYSEAMERICAN:MYO) on 5/25/2023 |
FEAM 5E Advanced Materials | $0.47
+3.6% | 5/24/2023 | Initiated by | Maxim Group | - | Hold | | Low | View details for Maxim Group rating of 5E Advanced Materials (NASDAQ:FEAM) on 5/24/2023 |
IMMP Immutep | $2.03
-4.2% | 5/17/2023 | Target Raised by | Maxim Group | - | | $8.00 -> $10.00 | Low | View details for Maxim Group rating of Immutep (NASDAQ:IMMP) on 5/17/2023 |
HGBL Heritage Global | $1.75
+0.6% | 5/15/2023 | Target Raised by | Maxim Group | - | | $4.00 -> $4.50 | Low | View details for Maxim Group rating of Heritage Global (NASDAQ:HGBL) on 5/15/2023 |
FLUX Flux Power | $1.71
+7.5% | 5/12/2023 | Target Lowered by | Maxim Group | - | | $10.00 -> $9.00 | Low | View details for Maxim Group rating of Flux Power (NASDAQ:FLUX) on 5/12/2023 |
CHRS Coherus BioSciences | $1.52
+2.7% | 5/12/2023 | Target Lowered by | Maxim Group | - | | $15.00 -> $12.00 | Low | View details for Maxim Group rating of Coherus BioSciences (NASDAQ:CHRS) on 5/12/2023 |
SCPH scPharmaceuticals | $3.39
+2.4% | 5/11/2023 | Target Raised by | Maxim Group | - | | $13.00 -> $20.00 | Low | View details for Maxim Group rating of scPharmaceuticals (NASDAQ:SCPH) on 5/11/2023 |
CELH Celsius | $27.01
-3.3% | 5/10/2023 | Target Raised by | Maxim Group | - | Buy | $43.33 -> $46.67 | Low | View details for Maxim Group rating of Celsius (NASDAQ:CELH) on 5/10/2023 |
ACHV Achieve Life Sciences | $3.69
-3.4% | 5/10/2023 | Target Raised by | Maxim Group | Analyst Jason McCarthy | Buy | $8.00 -> $20.00 | Low | View details for Maxim Group rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/10/2023 |
PALT Paltalk | $1.68
+5.2% | 5/10/2023 | Upgraded by | Maxim Group | - | Hold -> Buy | | Low | View details for Maxim Group rating of Paltalk (NASDAQ:PALT) on 5/10/2023 |
NYMT New York Mortgage Trust | $5.94
+1.0% | 5/9/2023 | Target Lowered by | Maxim Group | - | | $14.00 -> $13.00 | Low | View details for Maxim Group rating of New York Mortgage Trust (NASDAQ:NYMT) on 5/9/2023 |
HEAR Turtle Beach | $15.96
-1.2% | 5/5/2023 | Target Raised by | Maxim Group | - | Buy | $10.00 -> $16.00 | N/A | View details for Maxim Group rating of Turtle Beach (NASDAQ:HEAR) on 5/5/2023 |
NWN Northwest Natural | $39.57
-0.1% | 5/5/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Northwest Natural (NYSE:NWN) on 5/5/2023 |
NVEE NV5 Global | $19.03
+0.4% | 5/5/2023 | Upgraded by | Maxim Group | - | Hold -> Buy | $31.25 | Low | View details for Maxim Group rating of NV5 Global (NASDAQ:NVEE) on 5/5/2023 |
VRTX Vertex Pharmaceuticals | $397.27
+0.2% | 5/3/2023 | Target Raised by | Maxim Group | - | | $325.00 -> $400.00 | Low | View details for Maxim Group rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/3/2023 |
RVPH Reviva Pharmaceuticals | $1.34
-10.7% | 5/3/2023 | Target Raised by | Maxim Group | - | | $10.00 -> $18.00 | Low | View details for Maxim Group rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 5/3/2023 |
OTTR Otter Tail | $75.17
+0.3% | 5/3/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Otter Tail (NASDAQ:OTTR) on 5/3/2023 |
CUBI Customers Bancorp | $47.71
+1.6% | 5/1/2023 | Target Raised by | Maxim Group | - | | $40.00 -> $45.00 | Low | View details for Maxim Group rating of Customers Bancorp (NYSE:CUBI) on 5/1/2023 |
ONDS Ondas | $1.47
+8.1% | 4/28/2023 | Initiated by | Maxim Group | - | Buy | | Low | View details for Maxim Group rating of Ondas (NASDAQ:ONDS) on 4/28/2023 |
EEX Emerald | $4.79
+3.0% | 4/27/2023 | Initiated by | Maxim Group | - | Buy | $12.00 | Low | View details for Maxim Group rating of Emerald (NYSE:EEX) on 4/27/2023 |
AUGX Augmedix | $2.35
| 4/21/2023 | Target Raised by | Maxim Group | - | Buy | $5.00 -> $8.00 | Low | View details for Maxim Group rating of Augmedix (OTCMKTS:AUGX) on 4/21/2023 |
BMI Badger Meter | $217.72
-0.3% | 4/21/2023 | Target Raised by | Maxim Group | - | Buy | $135.00 -> $152.00 | Low | View details for Maxim Group rating of Badger Meter (NYSE:BMI) on 4/21/2023 |
SWKH SWK | $15.80
-4.1% | 4/4/2023 | Target Lowered by | Maxim Group | - | Buy | $25.00 -> $22.00 | Low | View details for Maxim Group rating of SWK (NASDAQ:SWKH) on 4/4/2023 |
UGRO urban-gro | $1.07
+4.9% | 3/31/2023 | Target Lowered by | Maxim Group | - | Buy | $12.00 -> $7.00 | Low | View details for Maxim Group rating of urban-gro (NASDAQ:UGRO) on 3/31/2023 |
LINK Interlink Electronics | $6.26
+12.6% | 3/31/2023 | Target Raised by | Maxim Group | - | Buy | $12.00 -> $13.33 | Low | View details for Maxim Group rating of Interlink Electronics (NASDAQ:LINK) on 3/31/2023 |
BCLI Brainstorm Cell Therapeutics | $2.28
+9.6% | 3/31/2023 | Target Raised by | Maxim Group | - | Buy | $75.00 -> $150.00 | Low | View details for Maxim Group rating of Brainstorm Cell Therapeutics (NASDAQ:BCLI) on 3/31/2023 |
DLPN Dolphin Entertainment | $1.07
+1.9% | 3/31/2023 | Reiterated by | Maxim Group | - | Buy | $14.00 | Low | View details for Maxim Group rating of Dolphin Entertainment (NASDAQ:DLPN) on 3/31/2023 |
SCYX SCYNEXIS | $1.00
-1.0% | 3/30/2023 | Target Raised by | Maxim Group | - | | $7.00 -> $10.00 | Low | View details for Maxim Group rating of SCYNEXIS (NASDAQ:SCYX) on 3/30/2023 |
MNPR Monopar Therapeutics | $25.82
+8.5% | 3/29/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Monopar Therapeutics (NASDAQ:MNPR) on 3/29/2023 |
VKTX Viking Therapeutics | $42.25
+1.8% | 3/28/2023 | Target Raised by | Maxim Group | - | Buy | $15.00 -> $25.00 | Low | View details for Maxim Group rating of Viking Therapeutics (NASDAQ:VKTX) on 3/28/2023 |
MEDS TRxADE HEALTH | $7.58
-6.8% | 3/28/2023 | Target Lowered by | Maxim Group | - | Buy | $37.50 -> $26.25 | Low | View details for Maxim Group rating of TRxADE HEALTH (NASDAQ:MEDS) on 3/28/2023 |
BMTX BM Technologies | $4.80
+0.6% | 3/28/2023 | Target Lowered by | Maxim Group | - | | $15.00 -> $10.00 | Low | View details for Maxim Group rating of BM Technologies (NYSE:BMTX) on 3/28/2023 |
AUGX Augmedix | $2.35
| 3/28/2023 | Target Raised by | Maxim Group | - | Buy | $4.00 -> $5.00 | Low | View details for Maxim Group rating of Augmedix (OTCMKTS:AUGX) on 3/28/2023 |
PAYS Paysign | $2.99
+2.0% | 3/22/2023 | Target Raised by | Maxim Group | - | Buy | $3.50 -> $4.50 | Low | View details for Maxim Group rating of Paysign (NASDAQ:PAYS) on 3/22/2023 |
CYTH Cyclo Therapeutics | $0.63
+1.6% | 3/20/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Cyclo Therapeutics (NASDAQ:CYTH) on 3/20/2023 |
WISA WiSA Technologies | $1.70
-1.2% | 3/20/2023 | Target Lowered by | Maxim Group | - | | $1,500.00 -> $900.00 | Low | View details for Maxim Group rating of WiSA Technologies (NASDAQ:WISA) on 3/20/2023 |
ACHV Achieve Life Sciences | $3.69
-3.4% | 3/17/2023 | Reiterated by | Maxim Group | Analyst Jason McCarthy | Buy | $8.00 | Low | View details for Maxim Group rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/17/2023 |
ZVRA Zevra Therapeutics | $8.49
-0.6% | 3/17/2023 | Initiated by | Maxim Group | - | Buy | $12.00 | Low | View details for Maxim Group rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/17/2023 |
LOAN Manhattan Bridge Capital | $5.53
+1.1% | 3/16/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Manhattan Bridge Capital (NASDAQ:LOAN) on 3/16/2023 |
WISA WiSA Technologies | $1.70
-1.2% | 3/14/2023 | Target Lowered by | Maxim Group | - | | $1,500.00 | Low | View details for Maxim Group rating of WiSA Technologies (NASDAQ:WISA) on 3/14/2023 |
APRE Aprea Therapeutics | $3.05
-5.6% | 3/10/2023 | Initiated by | Maxim Group | - | Buy | | Low | View details for Maxim Group rating of Aprea Therapeutics (NASDAQ:APRE) on 3/10/2023 |
UNCY Unicycive Therapeutics | $0.68
-4.2% | 3/8/2023 | Target Raised by | Maxim Group | - | Buy | $3.00 -> $6.00 | Low | View details for Maxim Group rating of Unicycive Therapeutics (NASDAQ:UNCY) on 3/8/2023 |
DXR Daxor | $8.35
+2.6% | 3/3/2023 | Reiterated by | Maxim Group | Analyst Anthony Vendetti | Buy | $22.00 | N/A | View details for Maxim Group rating of Daxor (NYSEAMERICAN:DXR) on 3/3/2023 |
ALRM Alarm.com | $62.95
-2.2% | 2/27/2023 | Target Lowered by | Maxim Group | - | | $75.00 -> $70.00 | Low | View details for Maxim Group rating of Alarm.com (NASDAQ:ALRM) on 2/27/2023 |
UIS Unisys | $6.54
-3.3% | 2/24/2023 | Downgraded by | Maxim Group | - | Buy -> Hold | | Low | View details for Maxim Group rating of Unisys (NYSE:UIS) on 2/24/2023 |
XPER Xperi | $10.19
-0.1% | 2/22/2023 | Target Lowered by | Maxim Group | - | Buy | $23.00 -> $19.00 | Low | View details for Maxim Group rating of Xperi (NASDAQ:XPER) on 2/22/2023 |
TOPS Top Ships | $5.75
+4.5% | 2/22/2023 | Upgraded by | Maxim Group | - | Hold -> Buy | $30.00 | Low | View details for Maxim Group rating of Top Ships (NASDAQ:TOPS) on 2/22/2023 |
ESEA Euroseas | $34.22
+3.4% | 2/16/2023 | Target Lowered by | Maxim Group | - | | $36.00 -> $30.00 | Low | View details for Maxim Group rating of Euroseas (NASDAQ:ESEA) on 2/16/2023 |
NEOV NeoVolta | $4.71
+0.4% | 2/15/2023 | Target Lowered by | Maxim Group | - | Buy | $8.00 -> $5.00 | Low | View details for Maxim Group rating of NeoVolta (NASDAQ:NEOV) on 2/15/2023 |
EDRY EuroDry | $10.66
| 2/14/2023 | Target Lowered by | Maxim Group | - | Buy | $34.00 -> $30.00 | Low | View details for Maxim Group rating of EuroDry (NASDAQ:EDRY) on 2/14/2023 |
ZIVO ZIVO Bioscience | $19.00
+0.9% | 2/13/2023 | Target Lowered by | Maxim Group | - | | $54.00 -> $36.00 | Low | View details for Maxim Group rating of ZIVO Bioscience (NASDAQ:ZIVO) on 2/13/2023 |
SRTS Sensus Healthcare | $7.10
-1.5% | 2/10/2023 | Reiterated by | Maxim Group | Analyst Anthony Vendetti | Buy | $20.00 | Low | View details for Maxim Group rating of Sensus Healthcare (NASDAQ:SRTS) on 2/10/2023 |
FLUX Flux Power | $1.71
+7.5% | 2/10/2023 | Target Raised by | Maxim Group | - | | $6.00 -> $10.00 | Low | View details for Maxim Group rating of Flux Power (NASDAQ:FLUX) on 2/10/2023 |
TWO Two Harbors Investment | $11.87
+3.2% | 2/10/2023 | Upgraded by | Maxim Group | - | Hold -> Buy | $19.00 | Low | View details for Maxim Group rating of Two Harbors Investment (NYSE:TWO) on 2/10/2023 |
LINK Interlink Electronics | $6.26
+12.6% | 2/6/2023 | Initiated by | Maxim Group | - | Buy | | Low | View details for Maxim Group rating of Interlink Electronics (NASDAQ:LINK) on 2/6/2023 |
AGNC AGNC Investment | $9.45
+1.9% | 2/1/2023 | Target Raised by | Maxim Group | - | Buy | $9.00 -> $12.00 | Low | View details for Maxim Group rating of AGNC Investment (NASDAQ:AGNC) on 2/1/2023 |
LC LendingClub | $16.46
+1.0% | 1/31/2023 | Target Lowered by | Maxim Group | - | | $20.00 -> $15.00 | Low | View details for Maxim Group rating of LendingClub (NYSE:LC) on 1/31/2023 |
WKSP Worksport | $0.83
+1.0% | 1/20/2023 | Target Lowered by | Maxim Group | - | Buy | $5.50 -> $3.00 | Low | View details for Maxim Group rating of Worksport (NASDAQ:WKSP) on 1/20/2023 |
NIC Nicolet Bankshares | $106.01
+0.5% | 1/19/2023 | Target Lowered by | Maxim Group | - | | $110.00 -> $100.00 | Low | View details for Maxim Group rating of Nicolet Bankshares (NYSE:NIC) on 1/19/2023 |
